U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06821594) titled 'Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts At Tertiary Care Hospital in Karachi.' on Feb. 06.
Brief Summary: Identify the effects of combined intralesional furosemide 20mg/2ml and digoxin 0.5mg/2ml in cutaneous warts given weekly are rather safe and effective treatment for cutaneous warts, focusing on their effectiveness and safety, at a tertiary care hospital in Karachi, Pakistan.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Cutaneous Warts
Intervention:
DRUG: Furosemide
Furosemide 20mg/2ml and digoxin 0.5mg/2ml given 0.2 ml into the wart base once weekly for 5 w...